BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6607806)

  • 1. The influence of the lpr gene on B cell activation: differential antibody expression in lpr congenic mouse strains.
    Warren RW; Caster SA; Roths JB; Murphy ED; Pisetsky DS
    Clin Immunol Immunopathol; 1984 Apr; 31(1):65-77. PubMed ID: 6607806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of polyclonal B-cell activation in autoimmune B6-lpr/lpr mice.
    Warren RW; Roths JB; Murphy ED; Pisetsky DS
    Cell Immunol; 1984 Mar; 84(1):22-31. PubMed ID: 6199122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of the autoimmune B cell repertoire in MRL-lpr/lpr mice.
    Klinman DM; Eisenberg RA; Steinberg AD
    J Immunol; 1990 Jan; 144(2):506-11. PubMed ID: 2295800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype.
    Prud'Homme GJ; Park CL; Fieser TM; Kofler R; Dixon FJ; Theofilopoulos AN
    J Exp Med; 1983 Feb; 157(2):730-42. PubMed ID: 6600490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic control of inflammatory arthritis in congenic lpr mice.
    Gilkeson GS; Ruiz P; Grudier JP; Kurlander RJ; Pisetsky DS
    Clin Immunol Immunopathol; 1989 Dec; 53(3):460-74. PubMed ID: 2805451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of Yaa on anti-DNA responses of B6-lpr mice.
    Pisetsky DS; Klatt C; Dawson D; Roths JB
    Clin Immunol Immunopathol; 1985 Dec; 37(3):369-76. PubMed ID: 3931946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of various autoantibodies by mutant gene lpr in several strains of mice.
    Izui S; Kelley VE; Masuda K; Yoshida H; Roths JB; Murphy ED
    J Immunol; 1984 Jul; 133(1):227-33. PubMed ID: 6609979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment with 5,5-diphenylhydantoin reduces lymphadenopathy and anti-ssDNA autoantibodies in C57BL/6-lpr/lpr mice.
    Bloksma N; de Bakker JM; van Rooijen HJ; Punt P; Seinen W; Kammüller ME
    Int J Immunopharmacol; 1994 Mar; 16(3):261-8. PubMed ID: 8206693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of central B cell tolerance in autoimmune-prone MRL/lpr mice bearing autoantibody transgenes.
    Rubio CF; Kench J; Russell DM; Yawger R; Nemazee D
    J Immunol; 1996 Jul; 157(1):65-71. PubMed ID: 8683157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
    Merino R; Iwamoto M; Fossati L; Izui S
    J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-dependent isotype variation during secondary immune response in MRL/lpr mice producing autoanti-gamma-globulin antibodies.
    Manheimer A; Bona C
    Eur J Immunol; 1985 Jul; 15(7):718-22. PubMed ID: 2408902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of autoantibodies in normal mice by injection of nucleobindin and natural occurrence of antibodies against nucleobindin in autoimmune MRL/lpr/lpr mice.
    Kanai Y; Takeda O; Miura K; Amagai M; Kaneko T; Kubota T; Kanai Y; Tanuma S; Kurosawa Y
    Immunol Lett; 1995 Feb; 45(1-2):35-42. PubMed ID: 7622185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal rheumatoid factors from B6-lpr/lpr mice.
    Warren RW; Sailstad DM; Pisetsky DS
    Clin Exp Immunol; 1984 Dec; 58(3):731-6. PubMed ID: 6509801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with dextran-conjugated anti-IgD delays the development of autoimmunity in MRL-lpr/lpr mice.
    Shirai A; Aoki I; Otani M; Mond JJ; Klinman DM
    J Immunol; 1994 Aug; 153(4):1889-94. PubMed ID: 7519219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice.
    Santoro TJ; Portanova JP; Kotzin BL
    J Exp Med; 1988 May; 167(5):1713-8. PubMed ID: 3259258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of heterozygous lpr gene in MRL mice. I. Defective T-cell reactivity and polyclonal B-cell activation.
    Carlsten H; Tarkowski A
    Scand J Immunol; 1989 Oct; 30(4):457-62. PubMed ID: 2814366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between induced and spontaneous autoantibodies in MRL mice: the role of Ly-1 B cells?
    Bond A; Hay FC; Cooke A
    Immunology; 1988 Jun; 64(2):325-9. PubMed ID: 3292411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C57B1/6 nu/nu, lpr/lpr mouse. III. Autoimmunity status.
    Mosbach-Ozmen L; Gaveriaux C; Montecino-Rodriguez E; Loor F
    Thymus; 1986; 8(1-2):59-75. PubMed ID: 3088780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease.
    Xu M; Hou R; Sato-Hayashizaki A; Man R; Zhu C; Wakabayashi C; Hirose S; Adachi T; Tsubata T
    J Immunol; 2013 Jun; 190(11):5436-45. PubMed ID: 23616572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isotype progression and clonality of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice.
    Eisenberg RA; Craven SY; Cohen PL
    J Immunol; 1987 Aug; 139(3):728-33. PubMed ID: 3474277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.